Effect of soft tissue augmentation with autologeous epithelialized connective tissue grafts in the treatment of periimplantitis: A randomised controlled clinical trial
Not Applicable
Recruiting
- Conditions
- K10.9Disease of jaws, unspecified
- Registration Number
- DRKS00032251
- Lead Sponsor
- Mund-Kiefer-Gesichtschirurgie der LM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Periimplantitis (Renvert et. al. 2018), less than 2mm keratinized periimplant mucosa or periimplant mucosa non-attached, healthy patient (ASA I-II), non-smoker, good oral hygiene, able to follow study protocol, periodontally healthy
Exclusion Criteria
pregnant, implant mobility, irrational to treat implant (>80% bone loss), more than 2mm keratinized periimplant mucosa that is attached at the same time
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Implant survival and success periimplantitis treatment after 12,24,60 months according to Herrera et. al. 2023
- Secondary Outcome Measures
Name Time Method After 12,24,60 months after therapy<br>periimplant mucositis, periodontal probing depths, attachment level, dimensional changes of epithelialized free gingival graft, width of keratinized mucosa, 3-dimensional evaluation of periimplant defect